Picture of Ergomed logo

ERGO — Ergomed Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Ergomed, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line4.9912.614.315-6.68
Depreciation
Non-Cash Items3.340.4762.732.8112.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.2520.101-3.36-8.78-7.78
Change in Accounts Receivable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities11.81818.714.82.95
Capital Expenditures-0.996-0.974-0.983-1.92-2.4
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1.83-11.8-3.16-24.2-2.19
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-2.83-12.8-4.15-26.1-4.59
Financing Cash Flow Items0-0.157-0.169-0.761-0.622
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.25-0.477-2.11-2.37-1.84
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash9.074.7412.2-12.1-4.15